Charles River Laboratories (Massachusetts) Adds Craig B. Thompson, M.D. To Board Of Directors

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Craig B. Thompson, M.D., President and Chief Executive Officer, Memorial Sloan-Kettering Cancer Center, to its Board of Directors. Dr. Thompson’s extensive experience with both global pharmaceutical companies and leading academic institutions in the fields of cancer biology and immunology will provide Charles River with a unique combination of expertise.

Help employers find you! Check out all the jobs and post your resume.